First Time Loading...
A

Assertio Holdings Inc
NASDAQ:ASRT

Watchlist Manager
Assertio Holdings Inc
NASDAQ:ASRT
Watchlist
Price: 1.03 USD 1.98% Market Closed
Updated: May 5, 2024

Assertio Holdings Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Assertio Holdings Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Assertio Holdings Inc
NASDAQ:ASRT
Revenue
$152.1m
CAGR 3-Years
13%
CAGR 5-Years
-13%
CAGR 10-Years
1%
Johnson & Johnson
NYSE:JNJ
Revenue
$85.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$61.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$35.9B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
5%

Assertio Holdings Inc
Revenue Breakdown

Breakdown by Geography
Assertio Holdings Inc

Not Available

Breakdown by Segments
Assertio Holdings Inc

Total Revenue: 152.1m USD
100%
Product Sales, Net: 149.5m USD
98.3%
Indocin Products: 87.2m USD
57.4%
Rolvedon: 18.2m USD
12%
Otrexup: 12m USD
7.9%
Sympazan: 9.9m USD
6.5%
Sprix: 9.2m USD
6%
Cambia: 8.1m USD
5.3%
Royalties And Milestones: 2.4m USD
1.6%
Other Revenue: 200k USD
0.1%
Show More
Show Less

See Also

What is Assertio Holdings Inc's Revenue?
Revenue
152.1m USD

Based on the financial report for Dec 31, 2023, Assertio Holdings Inc's Revenue amounts to 152.1m USD.

What is Assertio Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
1%

Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Assertio Holdings Inc have been 13% over the past three years , -13% over the past five years , and 1% over the past ten years .